High cyclin E1 protein, but not gene amplification, is prognostic for basal‐like breast cancer

por Aziz, Diar, Lee, Christine, Chin, Venessa, Fernandez, Kristine J, Phan, Zoe, Waring, Paul, Caldon, C Elizabeth
Publicado 2022

Cyclin E2 Promotes Whole Genome Doubling in Breast Cancer

por Lee, Christine, Fernandez, Kristine J., Alexandrou, Sarah, Sergio, C. Marcelo, Deng, Niantao, Rogers, Samuel, Burgess, Andrew, Caldon, C. Elizabeth
Publicado 2020

MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer

por Portman, Neil, Milioli, Heloisa H., Alexandrou, Sarah, Coulson, Rhiannon, Yong, Aliza, Fernandez, Kristine J., Chia, Kee Ming, Halilovic, Ensar, Segara, Davendra, Parker, Andrew, Haupt, Sue, Haupt, Ygal, Tilley, Wayne D., Swarbrick, Alex, Caldon, C. Elizabeth, Lim, Elgene
Publicado 2020

Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibition

por Aziz, Diar, Portman, Neil, Fernandez, Kristine J., Lee, Christine, Alexandrou, Sarah, Llop-Guevara, Alba, Phan, Zoe, Yong, Aliza, Wilkinson, Ashleigh, Sergio, C. Marcelo, Ferraro, Danielle, Etemadmoghadam, Dariush, Bowtell, David D., Serra, Violeta, Waring, Paul, Lim, Elgene, Caldon, C. Elizabeth
Publicado 2021